Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeTadej Battelino, Moshe Phillip, Satish K. Garg et al.|Diabetes Care|2019Cited by 3.8k
International Consensus on Use of Continuous Glucose MonitoringThomas Danne, Moshe Phillip, Revital Nimri et al.|Diabetes Care|2017Cited by 2k
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trialVanita R. Aroda, J. Hans DeVries, Stephen C. Bain et al.|The Lancet Diabetes & Endocrinology|2017Cited by 439
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical PracticeMoshe Phillip, David C. Klonoff, Revital Nimri et al.|Endocrine Reviews|2022Cited by 398
Predisposing factors for hypoglycemia in the intensive care unit*Titia M. Vriesendorp, J. B. L. Hoekstra, J. Hans DeVries et al.|Critical Care Medicine|2005Cited by 281